Blemings, Allan

Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,391

Self-blinding citizen science to explore psychedelic microdosing

Szigeti, B., Kartner, L., Blemings, A., Rosas, F., Feilding, A., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2021) · eLife

Psychedelics and Drug StudiesPain Management and Placebo Effect

Cited by 192

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial

Laterre, P.-F., Berry, S. M., Blemings, A., Carlsen, J. E., François, B., Graves, T., Jacobsen, K., Lewis, R. J., Opal, S. M., Perner, A., et al. (2019) · JAMA

Sepsis Diagnosis and TreatmentHemodynamic Monitoring and Therapy

Cited by 147

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Russell, J. A., Vincent, J.-L., Kjølbye, A. L., Olsson, H., Blemings, A., Spapen, H., Carl, P., Laterre, P.-F., & Grundemar, L. (2017) · Critical Care

Sepsis Diagnosis and TreatmentHemodynamic Monitoring and Therapy

Cited by 103

Study Protocol for “Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study”

Spriggs, M. J., Douglass, H. M., Park, R. J., Read, T., Danby, J. L., de Magalhães, F. J. C., Alderton, K. L., Williams, T. M., Blemings, A., Lafrance, A., et al. (2021) · Frontiers in Psychiatry

Psychedelics and Drug StudiesEating Disorders and Behaviors

Cited by 75